{"id":"https://openalex.org/W4281979412","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.12089","title":"Association of metabolic risk factors with breast cancer survival in a population-based cohort.","display_name":"Association of metabolic risk factors with breast cancer survival in a population-based cohort.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281979412","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.12089"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.12089","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.12089","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.12089","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054048671","display_name":"Elizabeth M. Cespedes Feliciano","orcid":"https://orcid.org/0000-0003-1192-4017","observed_orcids":["https://orcid.org/0000-0003-1192-4017"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Feliciano","raw_affiliation_strings":["Kaiser Permanente Division of Research, Oakland, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente Division of Research, Oakland, CA;","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028926673","display_name":"Alexa Zimbalist","orcid":"https://orcid.org/0009-0001-1725-7377","observed_orcids":["https://orcid.org/0009-0001-1725-7377"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I4405284138","display_name":"Kaiser Permanente Northern California","ror":"https://ror.org/0302f6d89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4405284138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexa Zimbalist","raw_affiliation_strings":["Kaiser Permanente Northern California Division of Research, Oakland, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente Northern California Division of Research, Oakland, CA;","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4405284138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082578863","display_name":"Bette Jane Caan","orcid":"https://orcid.org/0000-0002-5803-310X","observed_orcids":["https://orcid.org/0000-0002-5803-310X"]},"institutions":[{"id":"https://openalex.org/I4405284138","display_name":"Kaiser Permanente Northern California","ror":"https://ror.org/0302f6d89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4405284138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bette Jane Caan","raw_affiliation_strings":["Kaiser Permanente Northern California, Oakland, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente Northern California, Oakland, CA;","institution_ids":["https://openalex.org/I4405284138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029062544","display_name":"Elizabeth Ann Mittendorf","orcid":"https://orcid.org/0000-0002-9762-8536","observed_orcids":["https://orcid.org/0000-0002-9762-8536"]},"institutions":[{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Mittendorf","raw_affiliation_strings":["Dana-Farber Brigham Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Brigham Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065796363","display_name":"Deborah A. R. Dillon","orcid":"https://orcid.org/0000-0002-4977-6673","observed_orcids":["https://orcid.org/0000-0002-4977-6673"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah Dillon","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052785465","display_name":"Charles P. Quesenberry","orcid":"https://orcid.org/0000-0001-8272-9126","observed_orcids":["https://orcid.org/0000-0001-8272-9126"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I4405284138","display_name":"Kaiser Permanente Northern California","ror":"https://ror.org/0302f6d89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4405284138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles P. Quesenberry","raw_affiliation_strings":["Kaiser Permanente Northern California, Division of Research, Oakland, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente Northern California, Division of Research, Oakland, CA;","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4405284138"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5115883330","display_name":"Wendy Y. Chen","orcid":"https://orcid.org/0000-0002-6946-1206","observed_orcids":["https://orcid.org/0000-0002-6946-1206"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Y. Chen","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"12089","last_page":"12089"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12103","display_name":"Cancer Risks and Factors","score":0.9437999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12103","display_name":"Cancer Risks and Factors","score":0.9437999725341797,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.03869999945163727,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7990000247955322},{"id":"https://openalex.org/keywords/breast-cancer-specific-mortality","display_name":"breast cancer-specific mortality","score":0.7940000295639038},{"id":"https://openalex.org/keywords/metabolic-risk-factors","display_name":"metabolic risk factors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9290000200271606},{"id":"https://openalex.org/keywords/low-hdl-cholesterol","display_name":"low HDL cholesterol","score":0.8769999742507935},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8370000123977661},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.765999972820282},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9649999737739563},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9810000061988831},{"id":"https://openalex.org/keywords/breast-cancer-prognosis","display_name":"breast cancer prognosis","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9322080612182617},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.8013445734977722},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6797006726264954},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5765540599822998},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5632582902908325},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.5344015955924988},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5280502438545227},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5051868557929993},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.4827503561973572},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.46158531308174133},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.33362001180648804},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.15386638045310974},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.12089","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.12089","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.12089","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313261556","https://openalex.org/W4409632085","https://openalex.org/W7171959208","https://openalex.org/W2145378054","https://openalex.org/W4361280416","https://openalex.org/W7130702389","https://openalex.org/W2318307739","https://openalex.org/W1993238391","https://openalex.org/W3110468417","https://openalex.org/W4413740941"],"abstract_inverted_index":{"12089":[0],"Background:":[1],"Metabolic":[2],"abnormalities":[3],"may":[4,263],"impact":[5],"breast":[6,66,76,121,188,200,248,268,296],"cancer":[7,30,47,67,77,157,231,242,249,253,269,297],"prognosis,":[8],"but":[9],"research":[10],"has":[11],"been":[12],"limited":[13],"by":[14],"small":[15],"samples":[16],"and":[17,32,44,65,91,139,141,145,152,156,162,213,233,255,280],"assessment":[18],"of":[19,112,120,160,180,187,210,252,293],"laboratory":[20,42],"values":[21,43,93,107],"at":[22,80,171],"a":[23,35,110,265],"single":[24],"time":[25,240],"point,":[26],"often":[27],"prior":[28],"to":[29,49,271],"diagnosis":[31,95,172,243,298],"treatment.":[33],"In":[34],"population":[36],"based":[37],"cohort,":[38],"we":[39],"utilized":[40],"time-updated":[41],"adjusted":[45,131],"for":[46,132,143,228],"treatment":[48,158,292],"assess":[50],"the":[51],"association":[52],"between":[53,115],"metabolic":[54,133,259],"risk":[55,220,260],"factors":[56],"(glucose,":[57],"high-density":[58],"lipoprotein":[59,62],"(HDL),":[60],"low-density":[61],"(LDL),":[63],"triglycerides)":[64],"survival.":[68],"Methods:":[69],"13,434":[70],"women":[71],"diagnosed":[72],"with":[73,126,191,222,246],"stage":[74],"I-III":[75],"from":[78,94,102],"2005-15":[79],"Kaiser":[81],"Permanente":[82],"were":[83,100,108,215],"included.":[84],"All":[85],"outpatient":[86],"fasting":[87],"glucose,":[88,211],"HDL,":[89],"LDL,":[90],"triglyceride":[92],"through":[96],"2019":[97],"or":[98,290],"death":[99],"extracted":[101],"electronic":[103],"medical":[104],"records.":[105],"Lab":[106],"updated":[109],"median":[111,178],"5":[113],"times":[114],"1-7":[116],"years":[117],"post-diagnosis.":[118],"Risk":[119],"cancer-specific":[122,201],"mortality":[123,202,250],"was":[124,173],"evaluated":[125,238],"Cox":[127],"proportional":[128],"hazards":[129],"models":[130],"labs,":[134],"demographics,":[135],"body":[136],"mass":[137],"index,":[138],"diabetes,":[140],"then":[142],"dyslipidemia":[144],"anti-hypertensive":[146],"medications,":[147],"tumor":[148,229],"characteristics":[149],"(stage,":[150],"ER":[151],"HER2":[153],"receptor":[154],"status)":[155],"(use":[159],"chemotherapy,":[161],"tamoxifen":[163],"v.":[164],"aromatase":[165],"inhibitors).":[166],"Results:":[167],"Mean":[168],"(SD)":[169],"age":[170],"62.3":[174],"(11.8)":[175],"years.":[176],"Over":[177],"follow-up":[179],"9":[181],"years,":[182],"2,876":[183],"patients":[184],"died":[185],"(1,080":[186],"cancer).":[189],"Patients":[190],"low":[192,223],"HDL":[193,224,237],"(\u226445":[194],"vs.":[195],">45":[196],"mg/dL)":[197],"had":[198],"higher":[199,247],"(HR,":[203],"1.87;":[204],"95%":[205],"CI,":[206],"1.62-2.16);":[207],"high":[208],"levels":[209],"triglycerides,":[212],"LDL":[214],"not":[216],"associated.":[217],"The":[218],"increased":[219],"associated":[221,245],"persisted":[225],"after":[226,241,295],"adjusting":[227],"characteristics,":[230],"treatment,":[232],"medications.":[234],"Conclusions:":[235],"Low":[236],"over":[239],"is":[244],"independent":[251],"treatments":[254],"changes":[256],"in":[257,267,274],"other":[258],"factors.":[261],"Cholesterol":[262],"play":[264],"role":[266,273],"due":[270],"its":[272],"cell":[275],"membrane":[276],"structure,":[277],"signaling":[278],"pathways,":[279],"steroid":[281],"hormone":[282],"synthesis.":[283],"Future":[284],"studies":[285],"should":[286],"address":[287],"whether":[288],"pharmacologic":[289],"lifestyle":[291],"lipids":[294],"can":[299],"optimize":[300],"survival":[301],"outcomes.[Table:":[302],"see":[303],"text]":[304]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2022-06-13T00:00:00"}